Search Results 371-380 of 14459 for albumin

1. Trametinib, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery - Mayo Clinic

   Albumin ≥ 2.5 g/dL; Total bilirubin ≤ 1.5 x institutional upper limit of normal (ULN); Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ...

2. AZD5305 Vs Placebo In Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents - Mayo Clinic

   Serum albumin ≥ 3.0 g/dL;. INR ≤ 1.5. Participants receiving oral anticoagulants may be enrolled with an INR < 2. Participants with other causes of INR ...

3. A Clinical Study Comparing Standard Anastomosis Closure Technique To Standard Closure Techniques Plus Sylys® Surgical Sealant - Mayo Clinic

   Albumin < 3 g/dL; ASA score (American Society of Anesthesiologists) ≥ 4; Neutropenia ≤ 800 cells/µl; Pregnancy; The following conditions involving compromised ...

4. Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score - Mayo Clinic

   Serum albumin ≥ 3.0 g/dL (within 120 days prior to registration). The patient must agree to use a condom (even men with vasectomies) and another effective ...

5. Terlipressin for HRS-AKI in Liver Transplant Candidates (INFUSE) (INFUSE) - Mayo Clinic

   ... albumin (given daily for two days - 48 hours minimum from 1st dose).If SCr improves by ≥ 20 % but plateaus ( ≤ 10 % fluctuation in sCr) and remains above ...

6. A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors - Mayo Clinic

   Albumin < 2.8 g/dL 5. ECG Exclusion a. Screening QTc interval > 450 milliseconds for males and QTc > 470 ms for females (corrected by Fridericia) 6. Other ...

7. Publications - Andrew R. Lewis, M.D. - Mayo Clinic

   Albumin-bilirubin grade as a prognostic indicator for patients with non-hepatocellular primary and metastatic liver malignancy undergoing Yttrium-90 ...

8. Comparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors - Mayo Clinic

   Albumin ≥ 3.0 g/dL. Concurrent somatostatin analog use while on protocol therapy is allowed provided that the patient: Has a functional tumor (evidence of ...

9. Study of IDO Inhibitor in Combination With Checkpoint Inhibitors for Adult Patients With Metastatic Melanoma - Mayo Clinic

   Serum Albumin ≥ 3 g/dL; Patients must have normal pituitary function as defined below: free T4, TSH within normal institutional limits; ACTH within normal ...

10. MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cancer - Mayo Clinic

    ... albumin-bound paclitaxel, or docetaxel. Histologic confirmation of the primary tumor is required. Eligible histologies include serous, endometrioid, clear ...